Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39282910

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Nov 14
First author
Powles T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Feb 6;392(6):618-619. doi: 10.1056/NEJMc2415733.
    note
    Source null
    related pmid
    39908437
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Feb 6;392(6):619. doi: 10.1056/NEJMc2415733.
    note
    Source null
    related pmid
    39908438
    relationship
    Comment in

Authors and identifiers

  1. name
    Powles T
    type
    Author
  2. name
    Catto JWF
    type
    Author
  3. name
    Galsky MD
    type
    Author
  4. name
    Al-Ahmadie H
    type
    Author
  5. name
    Meeks JJ
    type
    Author
  6. name
    Nishiyama H
    type
    Author
  7. name
    Vu TQ
    type
    Author
  8. name
    Antonuzzo L
    type
    Author
  9. name
    Wiechno P
    type
    Author
  10. name
    Atduev V
    type
    Author
  11. name
    Kann AG
    type
    Author
  12. name
    Kim TH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Powles T
    type
    Author
  2. name
    Catto JWF
    type
    Author
  3. name
    Galsky MD
    type
    Author
  4. name
    Al-Ahmadie H
    type
    Author
  5. name
    Meeks JJ
    type
    Author
  6. name
    Nishiyama H
    type
    Author
  7. name
    Vu TQ
    type
    Author
  8. name
    Antonuzzo L
    type
    Author
  9. name
    Wiechno P
    type
    Author
  10. name
    Atduev V
    type
    Author
  11. name
    Kann AG
    type
    Author
  12. name
    Kim TH
    type
    Author
bibliography ids
  1. nci-bib-976e2d1fa103bddd5f87b86d
book metadata
content sha256
7e3d2e3168fd9bfe18cab265997e07a0972a7f2bf8d994a403708aa33b61663a
document type
citation
dois
  1. 10.1056/NEJMoa2408154
electronic publication date
display
2024 Sep 15
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:39282910
immutable id
pubmed:39282910@7e3d2e3168fd9bfe18cab265997e07a0972a7f2bf8d994a403708aa33b61663a
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1773-1786
volume
391
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Feb 6;392(6):618-619. doi: 10.1056/NEJMc2415733.
    note
    Source null
    related pmid
    39908437
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Feb 6;392(6):619. doi: 10.1056/NEJMc2415733.
    note
    Source null
    related pmid
    39908438
    relationship
    Comment in
outcomes validated
false
pmid
39282910
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
31130b5cab937199bd94f69322f9390870d1d4e6a5549acf08cb525c9bcbd6c6
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2024 Nov 14
precision
day
year
2024
publication types
  1. Journal Article
  2. Clinical Trial, Phase III
  3. Randomized Controlled Trial
  4. Multicenter Study
  5. Comparative Study
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39282910/
title
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

Preserved source evidence · Not medical advice